Signos is a brand on a mission to tackle the obesity epidemic by providing a unique solution that combines continuous glucose monitoring (CGM) with an AI-driven app. Their goal is to deliver real-time glucose monitoring for optimal health and weight management. Signos translates an individual's metabolic signals into timely recommendations for eating, exercise, and overall better health.

The brand works by allowing its members to log their eating habits, which enables the Signos platform to understand each person's glucose reaction to specific foods. Once calibrated, Signos uses this data to provide personalized nutrition suggestions, including recommendations for the best foods, optimal eating times, and exercise routines to bring glucose levels back within the individual's optimal weight loss range. With nearly 75% of the American population overweight or obese, Signos aims to offer a new approach to weight loss and help people kickstart a healthier life.

The company was founded by Sharam Fouladgar-Mercer, who experienced his own struggles with weight and fitness. The executive team, including Chief of Data Science Bill Tancer, Chief Marketing Officer Hannah Russin, CAO Pierre Wehbe, VP of Product Emma Allison, and Stanford Physician Dr. William Dixon, is dedicated to providing personalized and meaningful experiences that empower individuals to take control of their health